Wearables
Dexcom G6 Continuous Glucose Monitor
Overview
Dexcom G6 scores high on effectiveness due to robust evidence from RCTs and real-world studies showing MARD ~9%, superior in dynamic conditions like exercise and ICU vs SMBG (e.g., PMC8323182: matched pairs analysis; PubMed 40803367: ICU accuracy). It reduces hypo events in trials like MOBILE study. Safety is moderate due to frequent recalls (Class I for missed alerts risking death) and common AEs like skin irritation (10-20% users per reviews/MAUDE), though rare severe outcomes.
Quality reflec
Key strengths
- High accuracy (MARD ~9%) validated in RCTs across populations (hospital, pregnancy, exercise)
- Real-time alerts and no fingersticks; interoperable with pumps (first iCGM)
- Improves glycemic control per MOBILE study (NCBI books/NBK279046)
Our analysis
Dexcom G6 is a reliable CGM with excellent accuracy backed by clinical studies, ideal for insulin users needing real-time data. Safety concerns from recalls and skin issues warrant caution; newer G7 or Libre 3 may suit cost/skin-sensitive users better.
Frequently asked questions
- Is Dexcom G6 Continuous Glucose Monitor worth buying?
- Dexcom G6 Continuous Glucose Monitor has a Verify Influencers trust score of 85/100 based on ingredient quality, clinical evidence, and third-party testing.
- What is the trust score for Dexcom G6 Continuous Glucose Monitor?
- Dexcom G6 Continuous Glucose Monitor scored 85 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.
Browse all scored products · How products are scored